Lentiviral Vectors Market Set To Witness Significant Growth By 2025-2032:Sino Biological, Inc., Takara Bio Inc, GENEMEDI
Lentiviral Vectors Market is estimated to be valued at US$ 292 million in 2023 and is expected to exhibit a CAGR of 18.5% during the forecast period (2023-2030) Mr. Shah Coherent Market Insights Pvt.
Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Pharmaceutical Technology4d
TCA-101 by TCR Cure Biopharma Technology for Endometrial Cancer: Likelihood of Approval
TCA-101 is under clinical development by TCR Cure Biopharma Technology and currently in Phase II for Endometrial Cancer.
Pharmaceutical Technology4d
Vebeglogene autotemcel by Lantu Biopharma for Beta Thalassaemia: Likelihood of Approval
Vebeglogene autotemcel is under clinical development by Lantu Biopharma and currently in Phase II for Beta Thalassaemia.
Taiwan News4d
Saudi Arabia Viral Vector and Plasmid DNA Manufacturing Market Industry Chain Information, Emerging Market Regions (2025-2033)
Anticipated growth for ‘Saudi Arabia Viral Vector and Plasmid DNA Manufacturing Market’ is significant from 2024 to 2032. The market showed steady growth in 2024 and is expected to continue rising due ...
Taiwan News4d
Vietnam Gene Therapy Market Future Innovations, Growth Elements, and Recent Development by 2033
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Gene Therapy Market offers comprehensive insights into the market landscape, customer intelligence, ...